BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wright LA, Hirsch IB. Metrics Beyond Hemoglobin A1C in Diabetes Management: Time in Range, Hypoglycemia, and Other Parameters. Diabetes Technol Ther. 2017;19:S16-S26. [PMID: 28541136 DOI: 10.1089/dia.2017.0029] [Cited by in Crossref: 70] [Cited by in F6Publishing: 68] [Article Influence: 17.5] [Reference Citation Analysis]
Number Citing Articles
1 Akturk HK, Garg S. Technological advances shaping diabetes care. Curr Opin Endocrinol Diabetes Obes 2019;26:84-9. [PMID: 30720477 DOI: 10.1097/MED.0000000000000467] [Cited by in Crossref: 10] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
2 Granda ML, Amarapurkar P, Fornoni A. Probing insulin sensitivity in diabetic kidney disease: is there a stronger role for functional imaging? Clin Sci (Lond) 2018;132:1085-95. [PMID: 29871909 DOI: 10.1042/CS20171490] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
3 Kahkoska AR, Adair LA, Aiello AE, Burger KS, Buse JB, Crandell J, Maahs DM, Nguyen CT, Kosorok MR, Mayer-Davis EJ. Identification of clinically relevant dysglycemia phenotypes based on continuous glucose monitoring data from youth with type 1 diabetes and elevated hemoglobin A1c. Pediatr Diabetes 2019;20:556-66. [PMID: 30972889 DOI: 10.1111/pedi.12856] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
4 Volčanšek Š, Lunder M, Janež A. Acceptability of Continuous Glucose Monitoring in Elderly Diabetes Patients Using Multiple Daily Insulin Injections. Diabetes Technol Ther 2019;21:566-74. [PMID: 31335199 DOI: 10.1089/dia.2019.0131] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
5 Adolfsson P, Parkin CG, Thomas A, Krinelke LG. Selecting the Appropriate Continuous Glucose Monitoring System - a Practical Approach. Eur Endocrinol 2018;14:24-9. [PMID: 29922348 DOI: 10.17925/EE.2018.14.1.24] [Cited by in Crossref: 25] [Cited by in F6Publishing: 10] [Article Influence: 6.3] [Reference Citation Analysis]
6 Forlenza GP, Lal RA. Current Status and Emerging Options for Automated Insulin Delivery Systems. Diabetes Technol Ther 2022. [PMID: 35099302 DOI: 10.1089/dia.2021.0514] [Reference Citation Analysis]
7 Liu F, Sirisena S, Ng K. Efficacy of flavonoids on biomarkers of type 2 diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials. Crit Rev Food Sci Nutr 2021;:1-27. [PMID: 34842001 DOI: 10.1080/10408398.2021.2009761] [Reference Citation Analysis]
8 Furler J, O'Neal D, Speight J, Blackberry I, Manski-Nankervis JA, Thuraisingam S, de La Rue K, Ginnivan L, Doyle R, Holmes-Truscott E, Khunti K, Dalziel K, Chiang J, Audehm R, Kennedy M, Clark M, Jenkins A, Lake AJ, Januszewski AS, Catchpool M, Liew D, Clarke P, Best J. Use of professional-mode flash glucose monitoring, at 3-month intervals, in adults with type 2 diabetes in general practice (GP-OSMOTIC): a pragmatic, open-label, 12-month, randomised controlled trial. Lancet Diabetes Endocrinol 2020;8:17-26. [PMID: 31862147 DOI: 10.1016/S2213-8587(19)30385-7] [Cited by in Crossref: 14] [Cited by in F6Publishing: 3] [Article Influence: 7.0] [Reference Citation Analysis]
9 McCance DR, Casey C. Type 1 Diabetes in Pregnancy. Endocrinol Metab Clin North Am 2019;48:495-509. [PMID: 31345519 DOI: 10.1016/j.ecl.2019.05.008] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
10 Aldawi N, Darwiche G, Abusnana S, Elbagir M, Elgzyri T. Initial increase in glucose variability during Ramadan fasting in non-insulin-treated patients with diabetes type 2 using continuous glucose monitoring. Libyan J Med 2019;14:1535747. [PMID: 30348064 DOI: 10.1080/19932820.2018.1535747] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
11 Helleputte S, De Backer T, Calders P, Pauwels B, Shadid S, Lapauw B. The Added and Interpretative Value of CGM-Derived Parameters in Type 1 Diabetes Depends on the Level of Glycemic Control. Endocrine Practice 2021;27:44-50. [DOI: 10.4158/ep-2020-0293] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 Hirsch IB, Wright EE Jr. Using Flash Continuous Glucose Monitoring in Primary Practice. Clin Diabetes 2019;37:150-61. [PMID: 31057221 DOI: 10.2337/cd18-0054] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
13 Mameli C, Cattaneo C, Lonoce L, Bedogni G, Redaelli FC, Macedoni M, Zuccotti G, Pagliarini E. Associations Among Taste Perception, Food Neophobia and Preferences in Type 1 Diabetes Children and Adolescents: A Cross-Sectional Study. Nutrients 2019;11:E3052. [PMID: 31847252 DOI: 10.3390/nu11123052] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
14 Vesco AT, Jedraszko AM, Garza KP, Weissberg-Benchell J. Continuous Glucose Monitoring Associated With Less Diabetes-Specific Emotional Distress and Lower A1c Among Adolescents With Type 1 Diabetes. J Diabetes Sci Technol 2018;12:792-9. [PMID: 29595061 DOI: 10.1177/1932296818766381] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 5.8] [Reference Citation Analysis]
15 Mancini G, Berioli MG, Santi E, Rogari F, Toni G, Tascini G, Crispoldi R, Ceccarini G, Esposito S. Flash Glucose Monitoring: A Review of the Literature with a Special Focus on Type 1 Diabetes. Nutrients 2018;10:E992. [PMID: 30060632 DOI: 10.3390/nu10080992] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 7.3] [Reference Citation Analysis]
16 Shuang W, Hui X, Ling L, Ping L. Time in range measurements for hyperglycemia management during pregnancy. Clin Chim Acta 2022;531:56-61. [PMID: 35339452 DOI: 10.1016/j.cca.2022.03.017] [Reference Citation Analysis]
17 Bellido V, Pinés-Corrales PJ, Villar-Taibo R, Ampudia-Blasco FJ. Time-in-range for monitoring glucose control: Is it time for a change? Diabetes Res Clin Pract 2021;177:108917. [PMID: 34126129 DOI: 10.1016/j.diabres.2021.108917] [Reference Citation Analysis]
18 Li J, Li Y, Ma W, Liu Y, Yin X, Xie C, Bai J, Zhang M. Association of Time in Range levels with Lower Extremity Arterial Disease in patients with type 2 diabetes. Diabetes Metab Syndr 2020;14:2081-5. [PMID: 33137566 DOI: 10.1016/j.dsx.2020.09.028] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
19 Tommerdahl KL, Shapiro ALB, Nehus EJ, Bjornstad P. Early microvascular complications in type 1 and type 2 diabetes: recent developments and updates. Pediatr Nephrol 2021. [PMID: 33852054 DOI: 10.1007/s00467-021-05050-7] [Reference Citation Analysis]
20 Hillman AR, Chrismas BCR. Thirty Days of Montmorency Tart Cherry Supplementation Has No Effect on Gut Microbiome Composition, Inflammation, or Glycemic Control in Healthy Adults. Front Nutr 2021;8:733057. [PMID: 34604282 DOI: 10.3389/fnut.2021.733057] [Reference Citation Analysis]
21 McMorrow R, Thuraisingam S, Furler J, Manski-Nankervis JA. Professional flash glucose monitoring and health service utilisation in type 2 diabetes: A secondary analysis of the GP-OSMOTIC study. Prim Care Diabetes 2021;15:178-83. [PMID: 32863148 DOI: 10.1016/j.pcd.2020.08.001] [Reference Citation Analysis]
22 Fan Y, Chou C, Bintoro BS, Pan W, Bai C. Combined Effect of Inflammation and Hyperglycemia on Mild Cognitive Impairment and Associated Dietary Patterns in an Older Taiwanese Population. Front Nutr 2022;9:791929. [DOI: 10.3389/fnut.2022.791929] [Reference Citation Analysis]
23 Redondo MJ, Libman I, Maahs DM, Lyons SK, Saraco M, Reusch J, Rodriguez H, DiMeglio LA. The Evolution of Hemoglobin A1c Targets for Youth With Type 1 Diabetes: Rationale and Supporting Evidence. Diabetes Care 2021;44:301-12. [PMID: 33431422 DOI: 10.2337/dc20-1978] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
24 Hirsch IB, Verderese CA. Professional Flash Continuous Glucose Monitoring with Ambulatory Glucose Profile Reporting to Supplement A1c: Rationale and Practical Implementation. Endocrine Practice 2017;23:1333-44. [DOI: 10.4158/ep171962.ra] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
25 RJ, Beck RW, Scioscia MF, Umpierrez GE, Tuttle KR. Glycemic Monitoring and management in advanced chronic kidney disease. Endocr Rev. 2020;41:756-774. [PMID: 32455432 DOI: 10.1210/endrev/bnaa017] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 9.0] [Reference Citation Analysis]
26 Bosoni P, Calcaterra V, Tibollo V, Malovini A, Zuccotti G, Mameli C, Sacchi L, Bellazzi R, Larizza C. Exploring the inter-subject variability in the relationship between glucose monitoring metrics and glycated hemoglobin for pediatric patients with type 1 diabetes. J Pediatr Endocrinol Metab 2021;34:619-25. [PMID: 33823102 DOI: 10.1515/jpem-2020-0725] [Reference Citation Analysis]
27 Musso G, Gambino R, Cassader M, Paschetta E. Efficacy and safety of dual SGLT 1/2 inhibitor sotagliflozin in type 1 diabetes: meta-analysis of randomised controlled trials. BMJ 2019;365:l1328. [PMID: 30967375 DOI: 10.1136/bmj.l1328] [Cited by in Crossref: 37] [Cited by in F6Publishing: 35] [Article Influence: 12.3] [Reference Citation Analysis]
28 Stone MP, Agrawal P, Chen X, Liu M, Shin J, Cordero TL, Kaufman FR. Retrospective Analysis of 3-Month Real-World Glucose Data After the MiniMed 670G System Commercial Launch. Diabetes Technol Ther 2018;20:689-92. [PMID: 30160523 DOI: 10.1089/dia.2018.0202] [Cited by in Crossref: 54] [Cited by in F6Publishing: 44] [Article Influence: 13.5] [Reference Citation Analysis]
29 von Oetinger G A, Trujillo G LM, Soto I N. [Impact of physical activity on glycemic variability in people with diabetes mellitus type 2]. Rehabilitacion (Madr) 2021:S0048-7120(20)30133-X. [PMID: 33865613 DOI: 10.1016/j.rh.2020.11.004] [Reference Citation Analysis]
30 Hirsch IB, Nardacci E, Verderese CA. Flash Continuous Glucose Monitoring: Implications for Use of Continuous Data in Daily Diabetes Management. Diabetes Spectr 2019;32:355-67. [PMID: 31798294 DOI: 10.2337/ds18-0059] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
31 Vigersky RA, Mcmahon C. The Relationship of Hemoglobin A1C to Time-in-Range in Patients with Diabetes. Diabetes Technology & Therapeutics 2019;21:81-5. [DOI: 10.1089/dia.2018.0310] [Cited by in Crossref: 116] [Cited by in F6Publishing: 100] [Article Influence: 38.7] [Reference Citation Analysis]
32 Garg SK, Akturk HK. Flash Glucose Monitoring: The Future Is Here. Diabetes Technol Ther 2017;19:S1-3. [PMID: 28541133 DOI: 10.1089/dia.2017.0098] [Cited by in Crossref: 8] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
33 Heinemann L, Freckmann G, Müller-Wieland D, Kellerer M. Critical Reappraisal of the Time-in-Range: Alternative or Useful Addition to Glycated Hemoglobin? J Diabetes Sci Technol 2020;14:922-7. [PMID: 31675907 DOI: 10.1177/1932296819883885] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
34 Elbalshy M, Haszard J, Smith H, Kuroko S, Galland B, Oliver N, Shah VN, de Bock MI, Wheeler BJ. Effect of Divergent Continuous Glucose Monitoring Technologies on Glycaemic Control in Type 1 Diabetes Mellitus: A Systematic Review and Meta-analysis of Randomised Controlled Trials. Diabet Med 2022;:e14854. [PMID: 35441743 DOI: 10.1111/dme.14854] [Reference Citation Analysis]
35 Inkeri J, Adeshara K, Harjutsalo V, Forsblom C, Liebkind R, Tatlisumak T, Thorn LM, Groop PH, Shams S, Martola J, Putaala J, Gordin D; FinnDiane Study Group. Glycemic control is not related to cerebral small vessel disease in neurologically asymptomatic individuals with type 1 diabetes. Acta Diabetol 2021. [PMID: 34778921 DOI: 10.1007/s00592-021-01821-8] [Reference Citation Analysis]
36 Kalra S, Shaikh S, Priya G, Baruah MP, Verma A, Das AK, Shah M, Das S, Khandelwal D, Sanyal D, Ghosh S, Saboo B, Bantwal G, Ayyagari U, Gardner D, Jimeno C, Barbary NE, Hafidh KA, Bhattarai J, Minulj TT, Zufry H, Bulugahapitiya U, Murad M, Tan A, Shahjada S, Bello MB, Katulanda P, Podgorski G, AbuHelaiqa WI, Tan R, Latheef A, Govender S, Assaad-Khalil SH, Kootin-Sanwu C, Joshi A, Pathan F, Nkansah DA. Individualizing Time-in-Range Goals in Management of Diabetes Mellitus and Role of Insulin: Clinical Insights From a Multinational Panel. Diabetes Ther 2021;12:465-85. [PMID: 33367983 DOI: 10.1007/s13300-020-00973-0] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
37 Klatman EL, Ogle GD. Access to insulin delivery devices and glycated haemoglobin in lower-income countries. World J Diabetes 2020; 11(8): 358-369 [PMID: 32864048 DOI: 10.4239/wjd.v11.i8.358] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
38 Reddy R, Wittenberg A, Castle JR, El Youssef J, Winters-Stone K, Gillingham M, Jacobs PG. Effect of Aerobic and Resistance Exercise on Glycemic Control in Adults With Type 1 Diabetes. Can J Diabetes 2019;43:406-414.e1. [PMID: 30414785 DOI: 10.1016/j.jcjd.2018.08.193] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 5.0] [Reference Citation Analysis]
39 Gomez-Peralta F, Abreu C, Gomez-Rodriguez S, Cruz-Bravo M, María-Sanchez C, Poza G, Ruiz-Valdepeñas L. Efficacy of Insulclock in Patients with Poorly Controlled Type 1 Diabetes Mellitus: A Pilot, Randomized Clinical Trial. Diabetes Technol Ther 2020;22:686-90. [PMID: 32069067 DOI: 10.1089/dia.2019.0427] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
40 Movsas TZ, Muthusamy A. Feasibility of neonatal haemoglobin A1C as a biomarker for retinopathy of prematurity. Biomarkers 2020;25:468-73. [PMID: 32552079 DOI: 10.1080/1354750X.2020.1783573] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
41 Guo Q, Zang P, Xu S, Song W, Zhang Z, Liu C, Guo Z, Chen J, Lu B, Gu P, Shao J. Time in Range, as a Novel Metric of Glycemic Control, Is Reversely Associated with Presence of Diabetic Cardiovascular Autonomic Neuropathy Independent of HbA1c in Chinese Type 2 Diabetes. J Diabetes Res. 2020;2020:5817074. [PMID: 32090120 DOI: 10.1155/2020/5817074] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 6.5] [Reference Citation Analysis]
42 Petrovski G, Al Khalaf F, Campbell J, Umer F, Almajaly D, Hamdan M, Hussain K. One-year experience of hybrid closed-loop system in children and adolescents with type 1 diabetes previously treated with multiple daily injections: drivers to successful outcomes. Acta Diabetol 2021;58:207-13. [PMID: 33044604 DOI: 10.1007/s00592-020-01607-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
43 Cadegiani FA, Kater CE. Hormonal response to a non-exercise stress test in athletes with overtraining syndrome: results from the Endocrine and metabolic Responses on Overtraining Syndrome (EROS) - EROS-STRESS. J Sci Med Sport 2018;21:648-53. [PMID: 29157780 DOI: 10.1016/j.jsams.2017.10.033] [Cited by in Crossref: 19] [Cited by in F6Publishing: 10] [Article Influence: 3.8] [Reference Citation Analysis]
44 Infante M, Padilla N, Alejandro R, Caprio M, Della-morte D, Fabbri A, Ricordi C. Diabetes-Modifying Antirheumatic Drugs: The Roles of DMARDs as Glucose-Lowering Agents. Medicina 2022;58:571. [DOI: 10.3390/medicina58050571] [Reference Citation Analysis]
45 Zhou L, Deng M, Zhai X, Yu R, Liu J, Yu M, Li Y, Xiao X. The Effects of Dietary Nutrition Intake on Glycemic Variability in Type 1 Diabetes Mellitus Adults. Diabetes Ther 2021;12:1055-71. [PMID: 33641082 DOI: 10.1007/s13300-021-01028-8] [Reference Citation Analysis]
46 van den Boom L, Buchal G, Kaiser M, Kostev K. Multimorbidity Among Adult Outpatients With Type 1 Diabetes in Germany. J Diabetes Sci Technol 2020;:1932296820965261. [PMID: 33095037 DOI: 10.1177/1932296820965261] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
47 Hansen KW, Bibby BM. Glycemic Metrics Derived From Intermittently Scanned Continuous Glucose Monitoring. J Diabetes Sci Technol. [DOI: 10.1177/1932296820975822] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
48 Kesavadev J, Misra A, Saboo B, Agarwal S, Sosale A, Joshi SR, Hussain A, Somasundaram N, Basit A, Choudhary P, Soegondo S. Time-in-range and frequency of continuous glucose monitoring: Recommendations for South Asia. Diabetes Metab Syndr 2021;16:102345. [PMID: 34920199 DOI: 10.1016/j.dsx.2021.102345] [Reference Citation Analysis]
49 Sherrill CH, Houpt CT, Dixon EM, Richter SJ. Professional continuous glucose monitoring: A retrospective cohort study comparing one vs two pharmacist‐driven encounters. J Am Coll Clin Pharm 2021;4:785-92. [DOI: 10.1002/jac5.1427] [Reference Citation Analysis]
50 Mattishent K, Lane K, Salter C, Dhatariya K, May HM, Neupane S, Loke YK. Continuous glucose monitoring in older people with diabetes and memory problems: a mixed-methods feasibility study in the UK. BMJ Open 2019;9:e032037. [PMID: 31740472 DOI: 10.1136/bmjopen-2019-032037] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
51 Pratley RE, Rosenstock J, Heller SR, Sinclair A, Heine RJ, Kiljański J, Brusko CS, Duan R, Festa A. Reduced Glucose Variability With Glucose-Dependent Versus Glucose-Independent Therapies Despite Similar Glucose Control and Hypoglycemia Rates in a Randomized, Controlled Study of Older Patients With Type 2 Diabetes Mellitus. J Diabetes Sci Technol 2018;12:1184-91. [PMID: 29893144 DOI: 10.1177/1932296818776993] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
52 Subramanian S, Hirsch IB. Diabetic Kidney Disease: Is There a Role for Glycemic Variability? Curr Diab Rep 2018;18:13. [PMID: 29450720 DOI: 10.1007/s11892-018-0979-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
53 Desouza CV, Holcomb RG, Rosenstock J, Frias JP, Hsia SH, Klein EJ, Zhou R, Kohzuma T, Fonseca VA. Results of a study comparing glycated albumin to other glycemic indices. J Clin Endocrinol Metab. 2020;105. [PMID: 31650161 DOI: 10.1210/clinem/dgz087] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
54 Xu SY, KeLi, Zhang Z, Liu CY, Guo QY, Lu B, Gu P, Shao JQ. Association between time in range, a novel measurement of glycemic control and islet secretory function in chinese patients with type 2 diabetes mellitus-An observational study. Diabetes Res Clin Pract 2021;173:108684. [PMID: 33539867 DOI: 10.1016/j.diabres.2021.108684] [Reference Citation Analysis]
55 Battelino T, Bosnyak Z, Danne T, Mukherjee B, Edelman S, Pilorget V, Choudhary P, Renard E, Bergenstal R. InRange: Comparison of the Second-Generation Basal Insulin Analogues Glargine 300 U/mL and Degludec 100 U/mL in Persons with Type 1 Diabetes Using Continuous Glucose Monitoring-Study Design. Diabetes Ther 2020;11:1017-27. [PMID: 32100192 DOI: 10.1007/s13300-020-00781-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
56 Fabris C, Heinemann L, Beck R, Cobelli C, Kovatchev B. Estimation of Hemoglobin A1c from Continuous Glucose Monitoring Data in Individuals with Type 1 Diabetes: Is Time In Range All We Need? Diabetes Technol Ther 2020;22:501-8. [PMID: 32459124 DOI: 10.1089/dia.2020.0236] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 8.0] [Reference Citation Analysis]
57 Feldman MA, Anderson LM, Shapiro JB, Jedraszko AM, Evans M, Weil LEG, Garza KP, Weissberg-Benchell J. Family-Based Interventions Targeting Improvements in Health and Family Outcomes of Children and Adolescents with Type 1 Diabetes: a Systematic Review. Curr Diab Rep 2018;18:15. [PMID: 29457190 DOI: 10.1007/s11892-018-0981-9] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 5.5] [Reference Citation Analysis]
58 Costa D, Lourenço J, Monteiro AM, Castro B, Oliveira P, Tinoco MC, Fernandes V, Marques O, Gonçalves R, Rolanda C. Clinical Performance of Flash Glucose Monitoring System in Patients with Liver Cirrhosis and Diabetes Mellitus. Sci Rep 2020;10:7460. [PMID: 32366878 DOI: 10.1038/s41598-020-64141-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
59 Chico A, Aguilera E, Ampudia-Blasco FJ, Bellido V, Cardona-Hernández R, Escalada FJ, Fernández D, Gómez-Peralta F, González Pérez de Villar N, Gorgojo JJ, Mezquita-Raya P, Morales C, de Pablos Velasco P, Palomares R, Parra J, Rivero MT, González-Blanco C. Clinical Approach to Flash Glucose Monitoring: An Expert Recommendation. J Diabetes Sci Technol 2020;14:155-64. [PMID: 31081362 DOI: 10.1177/1932296819841911] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
60 Krhač M, Lovrenčić MV. Update on biomarkers of glycemic control. World J Diabetes 2019; 10(1): 1-15 [PMID: 30697366 DOI: 10.4239/wjd.v10.i1.1] [Cited by in CrossRef: 29] [Cited by in F6Publishing: 21] [Article Influence: 9.7] [Reference Citation Analysis]
61 Advani A. Positioning time in range in diabetes management. Diabetologia 2020;63:242-52. [PMID: 31701199 DOI: 10.1007/s00125-019-05027-0] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 9.7] [Reference Citation Analysis]
62 Gurnurkar S, Owens L, Chalise S, Vyas N. Evaluation of Hemoglobin A1c before and after initiation of continuous glucose monitoring in children with type 1 diabetes mellitus. J Pediatr Endocrinol Metab 2021;34:311-7. [PMID: 33618445 DOI: 10.1515/jpem-2020-0587] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
63 Gabbay MAL, Rodacki M, Calliari LE, Vianna AGD, Krakauer M, Pinto MS, Reis JS, Puñales M, Miranda LG, Ramalho AC, Franco DR, Pedrosa HPC. Time in range: a new parameter to evaluate blood glucose control in patients with diabetes. Diabetol Metab Syndr 2020;12:22. [PMID: 32190124 DOI: 10.1186/s13098-020-00529-z] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 9.0] [Reference Citation Analysis]
64 Lundholm MD, Emanuele MA, Ashraf A, Nadeem S. Applications and pitfalls of hemoglobin A1C and alternative methods of glycemic monitoring. J Diabetes Complications 2020;34:107585. [PMID: 32553575 DOI: 10.1016/j.jdiacomp.2020.107585] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
65 Ehrmann D, Priesterroth L, Schmitt A, Kulzer B, Hermanns N. Associations of Time in Range and Other Continuous Glucose Monitoring-Derived Metrics With Well-Being and Patient-Reported Outcomes: Overview and Trends. Diabetes Spectr 2021;34:149-55. [PMID: 34149255 DOI: 10.2337/ds20-0096] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
66 Fagherazzi G, Ravaud P. Digital diabetes: Perspectives for diabetes prevention, management and research. Diabetes Metab 2019;45:322-9. [PMID: 30243616 DOI: 10.1016/j.diabet.2018.08.012] [Cited by in Crossref: 46] [Cited by in F6Publishing: 26] [Article Influence: 11.5] [Reference Citation Analysis]
67 Petrovski G, Al Khalaf F, Campbell J, Fisher H, Umer F, Hussain K. 10-Day structured initiation protocol from multiple daily injection to hybrid closed-loop system in children and adolescents with type 1 diabetes. Acta Diabetol 2020;57:681-7. [PMID: 31953687 DOI: 10.1007/s00592-019-01472-w] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
68 Palomino-Schätzlein M, Lamas-Domingo R, Ciudin A, Gutiérrez-Carcedo P, Marés R, Aparicio-Gómez C, Hernández C, Simó R, Herance JR. A Translational In Vivo and In Vitro Metabolomic Study Reveals Altered Metabolic Pathways in Red Blood Cells of Type 2 Diabetes. J Clin Med 2020;9:E1619. [PMID: 32471219 DOI: 10.3390/jcm9061619] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
69 Nguyen M, Han J, Spanakis EK, Kovatchev BP, Klonoff DC. A Review of Continuous Glucose Monitoring-Based Composite Metrics for Glycemic Control. Diabetes Technol Ther 2020;22:613-22. [PMID: 32069094 DOI: 10.1089/dia.2019.0434] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
70 Battelino T, Edelman SV, Nishimura R, Bergenstal RM. Comparison of Second-Generation Basal Insulin Analogs: A Review of the Evidence from Continuous Glucose Monitoring. Diabetes Technol Ther 2021;23:20-30. [PMID: 32700970 DOI: 10.1089/dia.2020.0180] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
71 Jing N, Pan M, Song Y, Guo F, Zhang H, Wang J, Cao Z, Liu S, Wu L, Ji H, Huang F, Ding X, Qi C, Huang S, Yang X, Zhang L, Song C, Qin G, Zhao Y. Renal outcomes and prognostic factors in patients with type-2 diabetes and chronic kidney disease confirmed by renal biopsy. Ther Adv Chronic Dis 2021;12:20406223211052388. [PMID: 34729158 DOI: 10.1177/20406223211052388] [Reference Citation Analysis]
72 Jones TW; ISPAD Hypoglycemia Guidelines Writing Group. Defining relevant hypoglycemia measures in children and adolescents with type 1 diabetes. Pediatr Diabetes 2018;19:354-5. [PMID: 29082592 DOI: 10.1111/pedi.12600] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
73 Hirsch IB. Professional flash continuous glucose monitoring as a supplement to A1C in primary care. Postgraduate Medicine 2017;129:781-90. [DOI: 10.1080/00325481.2017.1383137] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
74 Kim MY, Kim G, Park JY, Choi MS, Jun JE, Lee Y, Jin S, Hur KY, Kim JH. The Association Between Continuous Glucose Monitoring-Derived Metrics and Cardiovascular Autonomic Neuropathy in Outpatients with Type 2 Diabetes. Diabetes Technology & Therapeutics 2021;23:434-42. [DOI: 10.1089/dia.2020.0599] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
75 Wees I, Gunasekaran U, Meneghini L. Optimizing Glucose Meter Downloads at Parkland Diabetes Clinic. Clin Diabetes 2021;39:199-202. [PMID: 33986573 DOI: 10.2337/cd20-0056] [Reference Citation Analysis]
76 Kaushal T, Tinsley L, Volkening LK, Ambler-Osborn L, Laffel L. Improvement in Mean CGM Glucose in Young People with Type 1 Diabetes During 1 Year of the COVID-19 Pandemic. Diabetes Technol Ther 2021. [PMID: 34524008 DOI: 10.1089/dia.2021.0258] [Reference Citation Analysis]
77 Shifrin M, Siegelmann H. Near-optimal insulin treatment for diabetes patients: A machine learning approach. Artificial Intelligence in Medicine 2020;107:101917. [DOI: 10.1016/j.artmed.2020.101917] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
78 Valenzano M, Cibrario Bertolotti I, Valenzano A, Grassi G. Time in range-A1c hemoglobin relationship in continuous glucose monitoring of type 1 diabetes: a real-world study. BMJ Open Diabetes Res Care 2021;9:e001045. [PMID: 33514530 DOI: 10.1136/bmjdrc-2019-001045] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
79 Levin P, Hoogwerf BJ, Snell-Bergeon J, Vigers T, Pyle L, Bromberger L. Ultra Rapid-Acting Inhaled Insulin Improves Glucose Control in Patients With Type 2 Diabetes Mellitus. Endocr Pract 2021;27:449-54. [PMID: 33853718 DOI: 10.1016/j.eprac.2020.10.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]